Efficacy and Safety of Four Doses of Glycopyrronium Bromide (NVA237) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator Tiotropium
Clinical trial NCT00501852 · COMPLETED
Trial details
- NCT number
- NCT00501852
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2007-12-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.